Get the latest Science News and Discoveries
Alzheimer’s drug saga prompts journal to scrutinize whistle-blowers. Publication requires complainants to disclose financial conflicts in the wake of controversy over Cassava Sciences’ experimental treatment simufilam.
None
Or read this on r/EverythingScience